• Login
  • Join the Chamber
  • Find a Business
  • Contact Us
  • About Us
    • Meet Us
      • Mission and Vision
      • Board of Directors
      • Staff
      • Chamber Foundation
      • Regional Profile
    • Who We Work With
      • Regional Benefactors
      • Our Partners
      • Councils & Committees
      • Ambassadors and Regional Liaisons
  • Events
    • Chamber Events
    • Citizen of the Year
    • Download Past Webinars
    • Partner Events
    • Regional Events
  • Programs
    • Entrepreneur Academy
    • Young Professionals
    • Leadership Program
    • Regional Chamber Award Winners
  • Membership
    • Application
    • Membership Benefits
      • Membership Overview
      • 401k Multiple Employer Aggregation Program
      • Health Insurance
      • Member Discounts
    • Marketing Opportunities
      • Business Highlight
      • Advertise With Us
      • Host a Ribbon Cutting
      • Relocation Guide
    • Member Zone
      • Regional Chamber Award Winners
      • Find a Business
      • Login
      • FAQs (Member How-to’s)
      • Reserve the Conference Room
  • For Businesses
    • Start a Business
      • 10 Step Plan
      • Local EDC’s
      • CT Small Business Development Center
      • Media Contacts
      • Workshops + Seminars
    • Economic Development Intiatives
      • Entrepreneur Academy
      • Reopening Connecticut
      • Offshore Wind
      • Government Affairs
      • Arts, Culture, and Tourism
      • Thames River Innovation Place
      • SeCTer
      • ChooseCT.gov
    • Workforce Development
      • Eastern CT Workforce Investment Board
      • Young Professionals
      • Leadership Program
      • Workshops + Seminars
      • Career in STEM Quick Start Guide
  • For Residents
    • Regional Events
    • Job Openings
    • Military Community
    • Discount Card
  • For Visitors
    • Plan Your Trip
    • Request Information
    • CTVisit.com
  • Blog + News
    • Blog
    • Business News
    • Publications + Press

  • Member Login
  • Join The Chamber
  • Find a Business
  • Contact Us
ChamberECTChamberECT
Menu
  • About Us
    • Meet Us
      • Mission and Vision
      • Board of Directors
      • Staff
      • Chamber Foundation
      • Regional Profile
    • Who We Work With
      • Regional Benefactors
      • Our Partners
  • Programs + Events
    • Events
      • Chamber Events
      • Citizen of the Year
      • Download Past Webinars
      • Partner Events
      • Regional Events
    • Programs
      • Entrepreneur Academy
      • Young Professionals
      • Leadership Program
      • Regional Chamber Award Winners
  • Membership
    • Join
      • Application
    • Membership Benefits
      • Membership Overview
      • Health Insurance
      • 401k Multiple Employer Aggregation Program
      • Ambassadors and Regional Liaisons
      • Councils & Committees
      • Member Discounts
    • Marketing Opportunities
      • Business Highlight
      • Advertise With Us
      • Host a Ribbon Cutting
      • Relocation Guide
    • Member Zone
      • Find a Business
      • Login
      • FAQs (Member How-to’s)
      • Reserve the Conference Room
  • For Businesses
    • Start a Business
      • Entrepreneur Academy
      • 10 Step Plan
      • Local EDC’s
      • CT Small Business Development Center
      • Media Contacts
      • Workshops + Seminars
    • Economic Development Intiatives
      • Reopening Connecticut
      • Offshore Wind
      • Government Affairs
      • Arts, Culture, and Tourism
      • Thames River Innovation Place
      • SeCTer
      • ChooseCT.gov
    • Workforce Development
      • Eastern CT Workforce Investment Board
      • Young Professionals
      • Leadership Program
      • Workshops + Seminars
      • Career in STEM Quick Start Guide
  • For Residents
    • Regional Events
    • Job Openings
    • Military Community
  • For Visitors
    • Plan Your Trip
    • Request Information
    • CTVisit.com
  • Blog + News
    • Chamber Blog
    • Business News
    • Publications + Press

News

Share your news! Members can submit news and events in the member portal. Login to start submitting.

Results Found: 16
Button group with nested dropdown
Pfizer Connecticut Labs Opens Call fo...
Monday, January 24, 2022
Pfizer Connecticut Labs Opens Call for 2022 Community Grants

Local non-profit organizations are invited to apply for Pfizer Connecticut Laboratories 2022/2023 competitive grants.   Applications from organizations serving communities in Southeastern Connecticut, the greater New Haven area, and southern Rhode Island will be considered.   Priority will be given to programs that bring STEM (science, technology, engineering and math) to students from elementary through high school.   Additional grants will be made to programs that provide for the underserved,

Pfizer Global Research and Development
Pfizer and BioNTech Announce Positive  Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Monday, September 20, 2021
Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years

Results are the first from a pivotal trial of any COVID-19 vaccine in children under 12 years of ageIn participants 5 to 11 years of age, the vaccine was safe, well tolerated and showed robust neutralizing antibody responsesCompanies plan to submit these data to the FDA, EMA and other regulatory agencies around the world as soon as possibleResults in children under 5 years of age are expected as soon as later this year NEW YORK AND MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE

Pfizer Global Research and Development
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
Monday, August 23, 2021
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for COMIRNATY® (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 16 years of age and older. COMIRNATY is the first COVID-19 vaccine to be granted approval by the FDA. This press release features multimedia. View the full release

Pfizer Global Research and Development
Pfizer CT Announces Beginning of 2021 Community Grants Campaign   *NEW* Website and Application Process
Thursday, January 14, 2021
Pfizer CT Announces Beginning of 2021 Community Grants Campaign *NEW* Website and Application Process

Local non-profit organizations are invited to apply for Pfizer Connecticut’s 2021/2022 competitive grants. Applications from organizations serving communities in Southeastern Connecticut, the greater New Haven area, and southern Rhode Island will be considered. Priority will be given to programs that bring STEM (science, technology, engineering and math) to students from elementary through high school. Additional grants will be made to programs that provide for the underserved or to support local civic

Pfizer Global Research and Development
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
Monday, November 09, 2020
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study

Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysisAnalysis evaluated 94 confirmed cases of COVID-19 in trial participantsStudy enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collectedSubmission for Emergency Use Authorization (EUA) to the U.S. Food and Drug

Pfizer Global Research and Development
Pfizer and BioNTech  Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-Base Vaccine Candidate Against SARS-CoV-2
Wednesday, July 01, 2020
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-Base Vaccine Candidate Against SARS-CoV-2

In an ongoing U.S. Phase 1/2 placebo-controlled, observer-blinded clinical trial, nucleoside-modified messenger RNA vaccine candidate (BNT162b1) expressing the SARS-CoV-2 receptor binding domain (RBD) is being evaluated in 45 subjectsAt day 28 (7 days after dose 2), all subjects who received 10 or 30 µg of BNT162b1 had significantly elevated RBD-binding IgG antibodies with geometric mean concentrations (GMCs) of 4,813 and 27,872 units/ml which are 8- and 46.3-times, respectively, the GMC of 602 units/ml in

Pfizer Global Research and Development
Pfizer and BioNTech  Dose First Participants in the U.S. as Part of Global  COVID - 19 mRNA Vaccine
Tuesday, May 05, 2020
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID - 19 mRNA Vaccine

First participants dosed at NYU Grossman School of Medicine and University of Maryland School of Medicine Pfizer and BioNTech ramping up manufacturing capabilities to further increase production capacity in 2020/2021NEW YORK, USA, and MAINZ, Germany, May 5, 2020 – Pfizer Inc. (NYSE:PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global

Pfizer Global Research and Development
Pfizer Outlines Five-Point Plan to Battle COVID-19
Tuesday, March 17, 2020
Pfizer Outlines Five-Point Plan to Battle COVID-19

Chairman and CEO Albert Bourla Calls on Biopharma Industry to  Collaborate on Combatting the Global Pandemic    Pfizer issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19.  Dr. Albert Bourla, Chairman and CEO, made the following statement: “In this troubling time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic. Many companies, including Pfizer, are working to develop antiviral

Pfizer Global Research and Development
Pfizer Connecticut Labs Opens Call for 2020 Community Grants
Thursday, February 13, 2020
Pfizer Connecticut Labs Opens Call for 2020 Community Grants

Local non-profit organizations are invited to apply for Pfizer Connecticut Laboratories 2020/2021 competitive grants. Applications from organizations serving communities in Southeastern Connecticut, the greater New Haven area, and southern Rhode Island will be considered. Priority will be given to programs that bring STEM (science, technology, engineering and math) to students from elementary through high school. Additional grants will be made to programs that provide for the underserved or to support local

Pfizer Global Research and Development
Pfizer Awards Community Grants in Connecticut and Rhode Island
Friday, June 07, 2019
Pfizer Awards Community Grants in Connecticut and Rhode Island

Pfizer’s Groton Laboratories and the Clinical Research Unit, New Haven will support more than 60 programs in Southeastern Connecticut, the greater New Haven area, and southern Rhode Island through its 2019 competitive grants program. Priority was given to programs that bring science and math to students from elementary through high school. Additional awards were made for programs that provide for the underserved or to support local civic and cultural institutions. Groups receiving support in 2019

Pfizer Global Research and Development
Pfizer Connecticut Labs Opens Call for 2019 Community Grants
Friday, January 04, 2019
Pfizer Connecticut Labs Opens Call for 2019 Community Grants

Groton, CT – Local non-profit organizations are invited to apply for Pfizer Connecticut Laboratories’ 2019/2020 competitive grants. Applications from organizations serving communities in Southeastern Connecticut, the greater New Haven area, and southern Rhode Island will be considered. Priority will be given to programs that bring STEM (science, technology, engineering and math) to students from elementary through high school. Additional grants will be made to programs that provide for the underserved or to

Pfizer Global Research and Development
Pfizer Connecticut Labs Open Call for 2019 Community Grants
Friday, December 07, 2018
Pfizer Connecticut Labs Open Call for 2019 Community Grants

Beginning January 1, local non-profit organizations are invited to apply for Pfizer Connecticut Laboratories’ 2019/2020 competitive grants. Applications from organizations serving communities in Southeastern Connecticut, the greater New Haven area, and southern Rhode Island will be considered. Priority will be given to programs that bring STEM (science, technology, engineering and math) to students from elementary through high school. Additional grants will be made to programs that provide for the

Pfizer Global Research and Development
Pfizer Announces Community Grants for 2018
Friday, May 18, 2018
Pfizer Announces Community Grants for 2018

Pfizer’s Groton Laboratories and the Clinical Research Unit, New Haven will support more than 60 programs in Southeastern Connecticut, the greater New Haven area, and southern Rhode Island through its 2018 competitive grants program. Priority was given to programs that bring science and math to students from elementary through high school. Additional awards were made for programs that provide for the underserved or to support local civic and cultural institutions. Groups receiving support in 2018

Pfizer Global Research and Development
Pfizer Groton Labs Opens Call for 2018 Community Grants
Friday, January 05, 2018
Pfizer Groton Labs Opens Call for 2018 Community Grants

Local non-profit organizations are invited to apply for Pfizer Groton Laboratories’ 2018/2019 competitive grants. Applications from organizations serving communities in Southeastern Connecticut, the greater New Haven area, and southern Rhode Island will be considered. Priority will be given to programs that bring STEM (science, technology, engineering and math) to students from elementary through high school. Additional grants will be made to programs that provide for the underserved or to support local

Pfizer Global Research and Development
Pfizer Awards Community Grants
Thursday, June 15, 2017
Pfizer Awards Community Grants

Pfizer’s Groton Laboratories will support 67 programs in Southeastern Connecticut, the greater New Haven area, and southern Rhode Island through its 2017 competitive grants program. Priority was given to programs that bring science and math to students from elementary through high school. Additional awards were made for programs that provide for the underserved or to support local civic and cultural institutions. Groups receiving support in 2017 are: Aluminum Falcon Robotics Inc. - 2018 FIRST Robotics

Pfizer Global Research and Development
Pfizer Awards Grants to 51 of Region's Nonprofits
Tuesday, June 02, 2015
Pfizer Awards Grants to 51 of Region's Nonprofits

Pfizer Awards Grants to 51 of Region's Nonprofits Pfizer Inc. has announced that 51 nonprofits in Connecticut and Rhode Island, including the Garde Arts Center and Project Oceanology, will receive funding support this year. Other recipients were Aluminum Falcon Robotics, Bethsaida Community Inc., Center for Hospice Care Southeast Connecticut, Children's Museum of Southeastern Connecticut, Chorus of Westerly, Connecticut College, Eastern Connecticut Ballet, Eastern Connecticut Community Gardens

Pfizer Global Research and Development
Business Directory News Releases Events Calendar Member Discounts Military Discounts Marketspace Job Postings Contact Us Information & Brochures Weather Join The Chamber
GrowthZone - Membership Management Software

GET IN TOUCH

914 Hartford Turnpike, Waterford, CT 06385

(860) 701-9113

info@ChamberECT.com

QUICK LINKS

  • Chamber Events
  • Business Directory
  • Membership Overview
  • Membership Application
  • FAQs (Member How-to’s)
  • Regional Benefactors
  • Contact Us

NEWS + INFO

  • Chamber Blog
  • Member News
  • Sign Up for our Newsletters
  • Privacy Policy

© 2022 Chamber of Commerce of Eastern Connecticut, All Rights Reserved.